Sysmex (OTCMKTS:SSMXY – Get Free Report) posted its quarterly earnings data on Thursday. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.02), Zacks reports. Sysmex had a net margin of 8.86% and a return on equity of 9.27%. Sysmex updated its FY 2026 guidance to 0.370-0.370 EPS.
Sysmex Stock Down 4.0%
SSMXY stock traded down $0.34 during midday trading on Thursday, hitting $8.12. 553,102 shares of the company’s stock were exchanged, compared to its average volume of 267,723. The company has a current ratio of 3.33, a quick ratio of 2.44 and a debt-to-equity ratio of 0.12. Sysmex has a 12-month low of $8.12 and a 12-month high of $18.10. The firm has a 50 day moving average price of $8.75 and a 200-day moving average price of $9.42. The stock has a market capitalization of $5.11 billion, a price-to-earnings ratio of 16.92 and a beta of 1.10.
Analyst Upgrades and Downgrades
Separately, Citigroup lowered shares of Sysmex from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 16th. One research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold”.
About Sysmex
Sysmex Corporation (OTCMKTS: SSMXY) is a Japan‐based provider of in vitro diagnostic solutions, specializing in haematology, coagulation, urinalysis and immunochemistry systems. Headquartered in Kobe, the company designs and manufactures a comprehensive portfolio of automated analyzers, reagents and software to support clinical laboratories, hospitals and research institutions. Sysmex’s product lineup also includes digital pathology platforms and data management tools that integrate workflow automation and advanced analytics.
The company’s core offerings center on haematology analyzers such as the XN-Series, which deliver high‐speed, high‐volume testing for blood cell counts and differential analysis.
Recommended Stories
- Five stocks we like better than Sysmex
- YETI Rallies After Earnings Beat and Raised Outlook
- How the 3 Leading Quantum Firms Stack Up After Q1 Earnings
- Cisco’s Vertical Rally May Still Be in the Early Innings
- Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now
Receive News & Ratings for Sysmex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sysmex and related companies with MarketBeat.com's FREE daily email newsletter.
